2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors :: Lloyd-Jones DM
Morris PB
Ballantyne CM
Birtcher KK
Covington AM
DePalma SM
Minissian MB
Orringer CE
Smith SC Jr
Waring AA
Wilkins JT
Source :: Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 Oct 04; Vol. 80 (14), pp. 1366-1418. Date of Electronic Publication: 2022 Aug 25.
Publication Year :: 2022

Subjects :: Cholesterol, LDL
Consensus
Ezetimibe
Humans
United States epidemiology
Anticholesteremic Agents therapeutic use
Cardiology
Cardiovascular Diseases drug therapy
Cardiovascular Diseases epidemiology
Cardiovascular Diseases prevention & control
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use

Full Text Access

Tools